BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Nkarta to Participate in November 2025 Investor Conferences

  October 31, 2025

   · 

  1 min read
• Press Releases

  Synthekine Announces Late-Breaking Oral Presentation of Initial Clinical Data of STK-012 Plus Pembrolizumab and Chemotherapy in First-Line, PD-L1 Negative Nonsquamous NSCLC at SITC 2025 Annual Meeting

  October 31, 2025

   · 

  3 min read
• Press Releases

  Staloral® Birch Phase III Study Successfully Meets Primary Endpoint, Demonstrating Efficacy in Children and Adolescents

  October 31, 2025

   · 

  4 min read
• Press Releases

  Forlong Biotechology to Present Clinical Data from FL115, a novel interleukin-15 (IL-15) superagonist, in Late-breaking Session at 40th SITC Annual Meeting

  October 31, 2025

   · 

  3 min read
• Press Releases

  Amylyx Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025

  October 31, 2025

   · 

  1 min read
• Press Releases

  First Dual-Positive Immunotherapy with PFS and OS Benefit in EGFR+ NSCLC After EGFR-TKI Progression: Ivonescimab Final OS Analysis from HARMONi-A to Be Presented at SITC 2025

  October 31, 2025

   · 

  4 min read
• Press Releases

  Alpha Cognition (Nasdaq: ACOG) to Report Third Quarter 2025 Financial Results and Provide Business Update on Thursday, November 13, 2025

  October 31, 2025

   · 

  4 min read
• Press Releases

  Crown Bioscience Achieves Second CLIA Certification of 2025 at Suzhou Laboratory

  October 31, 2025

   · 

  2 min read
• Press Releases

  Novotech Maps Global Growth in Radiopharmaceutical Trials

  October 31, 2025

   · 

  3 min read
• Press Releases

  Alnylam Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Period Progress

  October 31, 2025

   · 

  19 min read